PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.21%
Revenue growth above 1.5x TSM's 11.63%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
20.51%
Gross profit growth above 1.5x TSM's 10.61%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
30.09%
EBIT growth above 1.5x TSM's 12.81%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
30.09%
Operating income growth above 1.5x TSM's 12.81%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
43.74%
Net income growth above 1.5x TSM's 23.21%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
40.00%
EPS growth above 1.5x TSM's 23.30%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
43.48%
Diluted EPS growth above 1.5x TSM's 23.30%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.01%
Share change of 1.01% while TSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.79%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.00%
Dividend reduction while TSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
64.11%
Positive OCF growth while TSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
67.13%
Positive FCF growth while TSM is negative. John Neff would see a strong competitive edge in net cash generation.
117.46%
10Y revenue/share CAGR at 50-75% of TSM's 182.95%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
125.94%
5Y revenue/share CAGR above 1.5x TSM's 60.17%. David Dodd would look for consistent product or market expansions fueling outperformance.
95.42%
3Y revenue/share CAGR above 1.5x TSM's 22.50%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
180.13%
10Y OCF/share CAGR above 1.5x TSM's 54.35%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
557.98%
Positive OCF/share growth while TSM is negative. John Neff might see a comparative advantage in operational cash viability.
387.45%
Positive 3Y OCF/share CAGR while TSM is negative. John Neff might see a big short-term edge in operational efficiency.
227.27%
Net income/share CAGR 1.25-1.5x TSM's 194.41%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
313.67%
5Y net income/share CAGR above 1.5x TSM's 71.44%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
340.13%
3Y net income/share CAGR above 1.5x TSM's 18.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
135.92%
10Y equity/share CAGR at 50-75% of TSM's 244.49%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
38.81%
Below 50% of TSM's 95.93%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
37.24%
3Y equity/share CAGR similar to TSM's 36.86%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.63%
3Y dividend/share CAGR at 75-90% of TSM's 77.78%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
-3.79%
Firm’s AR is declining while TSM shows 46.88%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.23%
Inventory shrinking or stable vs. TSM's 6.37%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
4.55%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.29%
Similar to TSM's 5.72%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-3.04%
We’re deleveraging while TSM stands at 14.57%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
11.06%
R&D growth drastically higher vs. TSM's 10.03%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
7.07%
We expand SG&A while TSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.